These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17467575)

  • 21. [New vaccination strategies].
    Plotkin SA
    Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in immunoinformatics: application of in silico tools to drug development.
    Evans MC
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):233-41. PubMed ID: 18283611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current methods of epitope identification for cancer vaccine design.
    Cherryholmes GA; Stanton SE; Disis ML
    Vaccine; 2015 Dec; 33(51):7408-7414. PubMed ID: 26238725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Computer aid vaccine design: new area of biomedical engineering].
    Huang J; You Z; Yao D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1039-42. PubMed ID: 15646361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for computer-aided chemical biology. Part 1: Design of a benchmark system for the evaluation of compound selectivity.
    Stumpfe D; Ahmed HE; Vogt I; Bajorath J
    Chem Biol Drug Des; 2007 Sep; 70(3):182-94. PubMed ID: 17718713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion.
    Gowthaman U; Agrewala JN
    J Proteome Res; 2008 Jan; 7(1):154-63. PubMed ID: 18034454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
    Poland GA; Ovsyannikova IG; Jacobson RM; Smith DI
    Clin Pharmacol Ther; 2007 Dec; 82(6):653-64. PubMed ID: 17971814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation.
    Sette A; Livingston B; McKinney D; Appella E; Fikes J; Sidney J; Newman M; Chesnut R
    Biologicals; 2001; 29(3-4):271-6. PubMed ID: 11851327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mining the Leishmania genome for novel antigens and vaccine candidates.
    Herrera-Najera C; Piña-Aguilar R; Xacur-Garcia F; Ramirez-Sierra MJ; Dumonteil E
    Proteomics; 2009 Mar; 9(5):1293-301. PubMed ID: 19206109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines.
    Bui HH; Sidney J; Li W; Fusseder N; Sette A
    BMC Bioinformatics; 2007 Sep; 8():361. PubMed ID: 17897458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomics: a 21st century approach to vaccine development for complex pathogens.
    De Sousa KP; Doolan DL
    Parasitology; 2016 Feb; 143(2):236-44. PubMed ID: 26864136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of databases, data mining and immunoinformatics in vaccinology: where are we?
    Hegde NR; Gauthami S; Sampath Kumar HM; Bayry J
    Expert Opin Drug Discov; 2018 Feb; 13(2):117-130. PubMed ID: 29226722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design.
    Kazi A; Chuah C; Majeed ABA; Leow CH; Lim BH; Leow CY
    Pathog Glob Health; 2018 May; 112(3):123-131. PubMed ID: 29528265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New horizons in adjuvants for vaccine development.
    Reed SG; Bertholet S; Coler RN; Friede M
    Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in veterinary vaccinology.
    Shams H
    Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of allergen ovalbumin using biofunctionalized magnetic beads packed in microfluidic channels The first step towards epitope-based vaccines.
    Jankovicova B; Rosnerova S; Slovakova M; Zverinova Z; Hubalek M; Hernychova L; Rehulka P; Viovy JL; Bilkova Z
    J Chromatogr A; 2008 Oct; 1206(1):64-71. PubMed ID: 18707690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Databases and in silico tools for vaccine design.
    He Y; Xiang Z
    Methods Mol Biol; 2013; 993():115-27. PubMed ID: 23568467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Software for rapid prototyping in the pharmaceutical and biotechnology industries.
    Kappler MA
    Curr Opin Drug Discov Devel; 2008 May; 11(3):389-92. PubMed ID: 18428093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.